SGLT2 Inhibitors in Type 2 Diabetes Management: Key Evidence and Implications for Clinical Practice

The above summary slide and prescribing tool represents the opinions of the authors. For a full list of declarations, including funding and author disclosure statements, please see the full text online (see “read the peer-reviewed publication” opposite).<br> © The authors, CC-BY-NC 2020.<b> </b>

上述摘要幻灯片及处方工具仅代表作者个人观点。如需获取包括资助信息与作者披露声明在内的完整声明列表，请在线查阅全文（参见页面另一侧标注为"阅读同行评议出版物"的链接）。© 作者，CC-BY-NC 2020。